PXS — Provexis Income Statement
0.000.00%
Last trade - 00:00
- £13.58m
- £12.73m
- £0.39m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.322 | 0.348 | 0.505 | 0.426 | 0.39 |
Cost of Revenue | |||||
Gross Profit | 0.273 | 0.312 | 0.456 | 0.38 | 0.294 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.856 | 0.773 | 0.865 | 0.666 | 0.811 |
Operating Profit | -0.534 | -0.425 | -0.359 | -0.24 | -0.421 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.533 | -0.424 | -0.359 | -0.24 | -0.42 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.533 | -0.424 | -0.359 | -0.24 | -0.387 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.513 | -0.406 | -0.341 | -0.224 | -0.385 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.513 | -0.406 | -0.341 | -0.224 | -0.385 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0 | -0 | -0 | -0 |